Through integrative bioinformatic analysis of The Cancer Genome Atlas (TCGA) dataset and validation using the Loma Linda University (LLU) patient cohort, we demonstrated that ITGB1, TIMP3, and BRAF function as key molecular determinants of SOC prognosis. This evidence concerns the gene TIMP3 and cancer.